DD295363A5 - Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten - Google Patents

Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten Download PDF

Info

Publication number
DD295363A5
DD295363A5 DD90342349A DD34234990A DD295363A5 DD 295363 A5 DD295363 A5 DD 295363A5 DD 90342349 A DD90342349 A DD 90342349A DD 34234990 A DD34234990 A DD 34234990A DD 295363 A5 DD295363 A5 DD 295363A5
Authority
DD
German Democratic Republic
Prior art keywords
benzyl
general formula
indazole
acid
hydroxymethyl
Prior art date
Application number
DD90342349A
Other languages
German (de)
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
�������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk�� filed Critical �������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk��
Publication of DD295363A5 publication Critical patent/DD295363A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DD90342349A 1989-02-07 1990-02-07 Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten DD295363A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
DD295363A5 true DD295363A5 (de) 1991-10-31

Family

ID=11261479

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90337657A DD291995A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren
DD90342349A DD295363A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD90337657A DD291995A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren

Country Status (36)

Country Link
US (2) US4999367A (fi)
EP (1) EP0382276B1 (fi)
JP (1) JP2870925B2 (fi)
KR (1) KR0145525B1 (fi)
CN (2) CN1046505C (fi)
AR (1) AR247386A1 (fi)
AT (1) ATE127115T1 (fi)
AU (1) AU624895B2 (fi)
BG (1) BG50273A3 (fi)
CA (1) CA2009503C (fi)
CZ (1) CZ280121B6 (fi)
DD (2) DD291995A5 (fi)
DE (2) DE382276T1 (fi)
DK (1) DK0382276T3 (fi)
EG (1) EG19170A (fi)
ES (1) ES2020171T3 (fi)
FI (1) FI102678B (fi)
GE (1) GEP19971030B (fi)
GR (2) GR910300073T1 (fi)
HU (1) HU204793B (fi)
IL (1) IL93132A (fi)
IN (1) IN170957B (fi)
IT (1) IT1230441B (fi)
LT (1) LT3604B (fi)
LV (1) LV10612B (fi)
NZ (1) NZ232258A (fi)
PE (1) PE25091A1 (fi)
PH (1) PH26552A (fi)
PL (2) PL163720B1 (fi)
PT (1) PT93067B (fi)
RO (1) RO106252B1 (fi)
RU (3) RU2066318C1 (fi)
SK (1) SK278441B6 (fi)
UA (1) UA26852C2 (fi)
YU (1) YU47943B (fi)
ZA (1) ZA90644B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EA018976B1 (ru) 2008-03-07 2013-12-30 Ацьенде Кимике Рьюните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии мср-1, cx3cr1 и p40
AU2009221089B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
KR101581829B1 (ko) 2008-03-07 2015-12-31 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸인다졸 유도체들 및 ｍｃｐ-1 및 ｃｘ3ｃｒ1의 발현을 기초로 한 질환들의 치료에서 이의 용도
KR101735577B1 (ko) 2009-08-03 2017-05-15 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 1-벤질-3-하이드록시메틸-1ｈ-인다졸과 이의 유도체의 제조 방법
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
WO2013163758A1 (en) 2012-05-01 2013-11-07 Boyd Shelley Romayne Methods for treating and diagnosing blinding eye diseases
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
US9346757B2 (en) 2012-05-18 2016-05-24 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
SI2882715T1 (sl) 2012-05-18 2017-03-31 Sanofi Derivati pirazola in njihova uporaba kot antagonisti LPAR5
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
US5112986A (en) 1992-05-12
EP0382276B1 (en) 1995-08-30
AU624895B2 (en) 1992-06-25
LV10612B (en) 1995-08-20
PE25091A1 (es) 1991-08-17
KR0145525B1 (ko) 1998-08-17
ZA90644B (en) 1991-01-30
NZ232258A (en) 1991-06-25
CN1034016C (zh) 1997-02-12
RU2044729C1 (ru) 1995-09-27
LTIP872A (en) 1995-03-27
RO106252B1 (ro) 1993-03-31
HU900689D0 (en) 1990-04-28
CZ280121B6 (cs) 1995-11-15
HU204793B (en) 1992-02-28
JPH02240065A (ja) 1990-09-25
US4999367A (en) 1991-03-12
SK56390A3 (en) 1997-05-07
ES2020171A4 (es) 1991-08-01
RU2055071C1 (ru) 1996-02-27
PT93067B (pt) 1995-12-29
CN1046505C (zh) 1999-11-17
DD291995A5 (de) 1991-07-18
DE382276T1 (de) 1991-11-28
UA26852C2 (uk) 1999-12-29
IT1230441B (it) 1991-10-23
CN1088201A (zh) 1994-06-22
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
FI900577A0 (fi) 1990-02-06
EP0382276A2 (en) 1990-08-16
IL93132A (en) 1994-05-30
LT3604B (en) 1995-12-27
RU2066318C1 (ru) 1996-09-10
PL163730B1 (pl) 1994-04-29
PH26552A (en) 1992-08-19
YU47943B (sh) 1996-07-24
DE69021902D1 (de) 1995-10-05
IL93132A0 (en) 1990-11-05
CZ56390A3 (en) 1995-06-14
LV10612A (lv) 1995-04-20
FI102678B (fi) 1999-01-29
GR910300073T1 (en) 1991-11-15
AR247386A1 (es) 1994-12-29
CA2009503A1 (en) 1990-08-07
JP2870925B2 (ja) 1999-03-17
ES2020171T3 (es) 1995-12-01
EG19170A (en) 1994-11-30
BG50273A3 (en) 1992-06-15
IN170957B (fi) 1992-06-20
ATE127115T1 (de) 1995-09-15
DE69021902T2 (de) 1996-05-23
YU20690A (sh) 1992-07-20
CA2009503C (en) 2000-04-11
KR900012913A (ko) 1990-09-03
GR3018165T3 (en) 1996-02-29
DK0382276T3 (da) 1996-01-15
AU4906690A (en) 1990-08-16
EP0382276A3 (en) 1990-12-12
PT93067A (pt) 1990-08-31
PL163720B1 (pl) 1994-04-29
SK278441B6 (en) 1997-05-07
CN1044810A (zh) 1990-08-22
HUT53088A (en) 1990-09-28
IT8947620A0 (it) 1989-02-07

Similar Documents

Publication Publication Date Title
EP0013376B1 (de) Ein Isoxazolderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel
DD295363A5 (de) Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten
DE2446010A1 (de) 4-(monoalkylamino)benzoesaeurederivate und verfahren zu ihrer herstellung
AT390054B (de) Verfahren zur herstellung von neuen benzoylderivaten von aliphatischen carbonsaeuren
EP0133935A2 (de) p-Oxibenzoesäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln mit hypolipämischer Wirkung
DE2511647A1 (de) Neue benzopyranderivate
DE2253914C3 (de) Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel
DE2307828A1 (de) (4-benzothiazolyl)-phenylessigsaeuren
DE1493083C (fi)
DE2526089C3 (de) Sauerstoff-heterocyclische Essigsäuren, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
DE1618465B2 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2328060B2 (de) 5-substituierte 3-Methylbenzo eckige Klammer auf b eckige Klammer zuthienyl (2)-essigsauren, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3235850A1 (de) Neue indolessigsaeureesterderivate und verfahren zur herstellung derselben
EP0017705A1 (de) Phenylalanyltryptophan-Derivate, sie enthaltende Arzneimittel, ihre Herstellung und Verwendung
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE3019834C2 (de) Ester von 2-(4-Isobutylphenyl)-propanol-1, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2609574B2 (de) 1-(4-fluor-3-trifluormethylthio- phenyl)-piperazin, dessen salze, verfahren zu dessen herstellung und arzneimittel
EP0009153B1 (de) Halogenierte Delta-Hydroxycarbonsäurederivate, Verfahren zu deren Herstellung und diese Derivate enthaltende neue Medikamente
DE2146676A1 (de) Cyclopropano- eckige Klammer auf b eckige Klammer zu -tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2505813C3 (de) 2-(4-Isobutylphenyl)-buttersäure, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0007347A1 (de) Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung.
DE2557517C3 (de) Phenylessigsäurederivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT284094B (de) Verfahren zur herstellung von neuen aryl-substituierten, teilweise gesaettigten bicycloaryloxyalkancarbonsaeuren und derivaten davon
DE2243305C3 (de) Neue Derivate von Phenylessigsäure, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, die die Derivate als Wirkstoff enthalten
DE2500692C3 (de) Derivate des 4-Amidoalkylen-4'oxy diphenyle

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100208